Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer
Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer
Recruiting · NCT07805252 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer | Advanced Solid Tumors Cancer | Recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT07805252 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Orion Corporation, Orion Pharma | 5 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinica Universidad de Navarra - Madrid | Madrid | Spain | 13 |
| Clínica Universidad de Navarra. Pamplona | Pamplona | Spain | 1 |
| Hospital Universitario Fundacion Jimenez Diaz - START MADRID | Madrid | Spain | 1 |
| NEXT Oncology - Hospital Quironsalud Madrid | Madrid | Spain | 1 |
| START Barcelona - HM Nou Delfos | Barcelona | Spain | 1 |
| START Madrid - CIOCC FM Sanchinarro | Madrid | Spain | 1 |
| START Rioja - Hospital Universitario San Pedro | Logroño | Spain | 2 |